Compare TRU & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRU | MEDP |
|---|---|---|
| Founded | 1968 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.5B | 13.4B |
| IPO Year | 2015 | 2016 |
| Metric | TRU | MEDP |
|---|---|---|
| Price | $84.15 | $542.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 12 |
| Target Price | $104.45 | ★ $465.18 |
| AVG Volume (30 Days) | ★ 1.7M | 268.8K |
| Earning Date | 10-23-2025 | 10-22-2025 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | ★ 87.22 | 25.36 |
| EPS | 2.14 | ★ 14.32 |
| Revenue | ★ $4,441,800,000.00 | $2,358,373,000.00 |
| Revenue This Year | $9.59 | $21.48 |
| Revenue Next Year | $7.57 | $11.90 |
| P/E Ratio | $39.35 | ★ $37.77 |
| Revenue Growth | 8.30 | ★ 13.88 |
| 52 Week Low | $66.38 | $250.05 |
| 52 Week High | $101.42 | $626.26 |
| Indicator | TRU | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 53.83 | 34.35 |
| Support Level | $82.16 | $585.65 |
| Resistance Level | $85.61 | $626.26 |
| Average True Range (ATR) | 2.12 | 18.47 |
| MACD | 0.18 | -7.23 |
| Stochastic Oscillator | 69.48 | 12.29 |
TransUnion is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services. TransUnion operates in over 30 countries. About 20%-25% of its revenue comes from international markets.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.